Olof Ulf Stefan Björklund
Direktor/Vorstandsmitglied bei ProNoxis AB
Ursprung des Netzwerks ersten Grades von Olof Ulf Stefan Björklund
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Swedish Pharmaceutical Society
5
| Non-Profit Organization | 5 | |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Olof Ulf Stefan Björklund
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CREATIVE ANTIBIOTICS SWEDEN AB | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
RECIPHARM AB (PUBL) | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
A+ Science Holding AB
A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden. | Miscellaneous | Director/Board Member | |
University of Uppsala | College/University | Graduate Degree Doctorate Degree | |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Private Equity Investor | |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Royal Institute of Technology | College/University | Graduate Degree Graduate Degree | |
University of Lund | College/University | Doctorate Degree | |
University of Gothenburg | College/University | Masters Business Admin | |
NATTOPHARMA ASA | Pharmaceuticals: Major | Director/Board Member | |
KDev Exploratory AB
KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder | |
PHARMACOLOG I UPPSALA AB | Electronic Equipment/Instruments | Director/Board Member | |
KCIF Fund Management AB | Chief Executive Officer | ||
IQVIA Clinical AB
IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Recipharm Stockholm AB | Director/Board Member Director/Board Member | ||
Recipharm Karlskoga AB
Recipharm Karlskoga AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Karlskoga AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member | |
Viogard AB
Viogard AB Marine ShippingTransportation Viogard AB is a holding company that develops techniques for the production of the active compounds. It conducts research that identified a number of substances which prevents fouling of marine organisms. It produces and sells substances and techniques with anti-fouling properties for protective coating products based on nature’s own defense mechanisms. The company was founded in 2006 by Martin Sjögren, Per Ivar Jösta Claeson and Erika Svangard and is headquartered in Stocksund, Sweden. | Marine Shipping | Director/Board Member | |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member | |
Läkemedelsverket | Corporate Officer/Principal | ||
Forskarpatent i Syd AB
Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chairman | |
Smartfish AS
Smartfish AS Food RetailRetail Trade Smartfish AS is a holding company that creates drinks for special medical purposes, as well as for people on the go and top athletes to improve their recovery and immune response. It is a research-based company that develops omega 3 based emulsions for brain health, heart health, immune system, and recovery. The firm’s product NutriFriend medical nutrition is sold through pharmacies, medical wholesalers, and directly to hospitals. The company was founded by Janne Sande Mathisen and Henrik Mathisen in 2001 and is headquartered in Oslo, Norway. | Food Retail | Director/Board Member | |
The Uppsala Monitoring Centre | Director/Board Member | ||
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Investment Officer | |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member | |
Forskarpatent I Uppsala AB | Chairman | ||
OSSDSIGN AB | Medical Specialties | Chairman | |
Uppsala Innovation Centre AB
Uppsala Innovation Centre AB Miscellaneous Commercial ServicesCommercial Services Uppsala Innovation Centre AB provides professional training services. The private company is based in Uppsala, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Recipharm Höganäs AB | Biotechnology | Director/Board Member | |
ExScale Biospecimen Solutions AB
ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Biotechnology | Director/Board Member | |
NEXTCELL PHARMA AB | Pharmaceuticals: Major | Founder | |
Kårhuset Pharmen AB | Director/Board Member | ||
NEPI Foundation
NEPI Foundation NEPI Foundation operates as a non-profit organization. The company was founded in 1993 and is headquartered in London, the United Kingdom. | Director/Board Member | ||
Vivendi Universal AB
Vivendi Universal AB Publishing: Books/MagazinesConsumer Services Vivendi Universal AB publishes music. | Publishing: Books/Magazines | Corporate Officer/Principal | |
Lakemedelsakademin Stockholm AB | Chairman | ||
Sphs Stockholm Congress AB | Chairman | ||
PCG Clinical Services AB | Chief Executive Officer |
Statistik
International
Schweden | 44 |
Norwegen | 4 |
Schweiz | 3 |
Dänemark | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 22 |
Commercial Services | 8 |
Consumer Services | 6 |
Finance | 3 |
Miscellaneous | 2 |
Operativ
Director/Board Member | 33 |
Corporate Officer/Principal | 15 |
Chairman | 11 |
Chief Executive Officer | 6 |
Graduate Degree | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Olof Ulf Stefan Björklund
- Unternehmensverbindungen